Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 4, 2011, Pages 915-923

  D'Arena, Giovanni ^a   Rossi, G ^b   Minervini, M M ^b   Savino, L ^b   D'Auria, F ^a   Laurenti, L ^c   Del Principe, M I ^d   Deaglio, S ^e   Biagi, A ^d   De Martino, L ^f   De Feo, V ^f   Statuto, T ^d   Musto, P ^a   Del Poeta, G ^d  

^a REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF SALERNO   (Italy)

Author keywords

Chronic lymphocytic leukemia; Monoclonal B cell lymphocytosis; Regulatory T cells

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MONOCLONAL B CELL LYMPHOCYTOSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TUMOR VOLUME; ADVANCED CANCER; CANCER SIZE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPARATIVE STUDY; DISEASE SEVERITY; ENZYME BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; LYMPHOCYTE COUNT; THROMBOCYTE COUNT;

CD38 ANTIGEN; HEMOGLOBIN; PROTEIN KINASE ZAP 70;

EID: 84856577660     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400410     Document Type: Article

References (25)

1. Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute - Working Group 1996 Guidelines. Blood 2008; 111:5446-56.
2. Shanafelt TD, Kay NE, Jenkins G, et al. B-cell count survival: differentiating chronic lymphocytic leukaemia (CLL) from monoclonal B-cell lymphocytosis (MBL) based on clinical outcome. Blood 2009; 113:4188-96.
3. Shanafelt TD, Kay NE, Call TG, Zent CS, Jelinek DF, Laplant B, Morice WG, Hanson CA. MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >/= 5 x 10(9)L(-1) but a B-cell lymphocyte count <5 x 10(9)L(-1)? Leuk Res 2008; 32:1458-61.
4. D'Arena G, Laurenti L, Minervini MM, et al. Regulatory t-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease. Leuk Res 2011; 35:363-68.
5. Beyer M, Schultze JL. Regulatory T cells in cancer. Blood 2006; 108:804-11. (Pubitemid 44154611)
6. Sakaguchi S, Wing K, Miyara M. Regulatory T cells - a brief history and perspective. Eur J Immunol 2007; 37:S116-23. (Pubitemid 350131275)
7. Baecher-Allan C, Hafler DA. Human regulatory T cells and their role in autoimmune disease. Immunol Rev 2006; 212:203-16. (Pubitemid 44116710)
8. Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, Kay N, Schleinitz TA, Caporaso N. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005; 130:325-32. (Pubitemid 43899581)
9. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46:219-34.
10. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48:198-206. (Pubitemid 11064396)
11. Liu W, Putnam AL, Xu-yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells. J Exp Med 2006; 203:1701-11. (Pubitemid 44036276)
12. Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203:1693-700. (Pubitemid 44036275)
13. Shanafelt TD, Ghia P, Lanasa MC, Landgren O, Rawstron AC. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia 2010; 24:512-20.
14. Shanafelt TD, Kay NE, Rabe KG, et al. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol 2009; 24:3959-63.
15. Scarfò L, Dagklis A, Scielzo C, Fazi C, Ghia P. CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it? Semin Cancer Biol 2010; 20:384-90.
16. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133:775-87. (Pubitemid 351707693)
17. Ha T-Y. The role of regulatory T cells in cancer. Immune Network 2009; 9:209-35.
18. D'Arena G, Deaglio S, Laurenti L, et al. Targeting regulatory T cells for anticancer therapy. Mini Rev Med Chem 2011; 11:480-85.
19. Beyer M, Kochanek M, Darabi K, et al. Reduced frequencies and suppressive function of CD4+CD25 high regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood 2005; 106:2018-25. (Pubitemid 41291715)
20. Giannopoulos K, Schmitt M, Kowal M, Wlasiuk P, Bojarska-Junak A, Chen J, Rolinski J, Dmoszynska A. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia. Oncol Rep 2008; 20:677-82.
21. Giannopoulos K, Schmitt M, Wlasiuk P, Chen J, Bojarska-Junak A, Kowal M, Roliñski J, Dmoszyñska A. The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide. Leukemia 2008; 22:222-24.
22. Deutsch V, Perry C, Polliack A. Expansion of regulatory T cells in B chronic lymphocytic leukemia: enhanced 'brakes' on host immunity. Leuk Lymphoma 2009; 50:687-88.
23. Jak M, Mous R, Remmerswaal EBM, et al. Enhanced formation and survival of CD4+CD25hiFoxp3+ T-cells in chronic lymphocytic leukemia. Leuk Lymphoma 2009; 50:788-801.
24. Weiss L, Meichardt T, Egle A, Grabmer C, Greil R, Tinhofer I. Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia. Cancer 2011; 117:2163-69.
25. Lanasa MC, Weinberg JB. Immunologic aspects of monoclonal B-cell lymphocytosis. Immunol Res 2011; 49:269-80.